Search

everythinglearnresearchcommunity

for

Search:↓

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Some patients' hair grew back black and white after chemotherapy.

Skin reactions from cancer treatments might predict how well the treatments work.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Most patients experienced significant but reversible hair loss during treatment.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.